Sanofi Canada is pleased to announce that Nuvaxovid®, a protein-based, non-mRNA COVID-19 vaccine, will be available in all 10 provinces and the Yukon for the 2026-2027 season through provincial ...
Health Canada has authorized Moderna's mRNA vaccine for influenza, as well as its combination mRNA vaccine for flu and COVID-19.
LIBERTY met all primary/secondary endpoints, with lower 6-day TEAEs/ISRs/hypersensitivity (56.5% vs 91.4%) and systemic AEs (44.1% vs 68.1%) for VYD2311 than vaccine. Over 56 days, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results